Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05958342 · ClinicalTrials.gov registry record · Phase 2

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

A Phase 2 study of Trauma and Hemorrhage, sponsored by Jason Sperry.

Recruiting
Registry status
Phase 2
Development phase
1,050
Enrollment target
13
Study locations

NCT05958342 is a Phase 2 study of Trauma and Hemorrhage that is actively recruiting participants, run by Jason Sperry. The registered enrollment target is 1,050 participants, above the 289-participant average among 56 other Trauma trials with a reported enrollment target (263% higher). The trial reports 13 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05958342, a Phase 2 study of Trauma and Hemorrhage, is actively recruiting participants, sponsored by Jason Sperry.

RECRUITING
Registry status
Phase 2
Development phase
1,050 participants
Enrollment target
13
Study locations

Study Summary

The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to determine the efficacy and safety of prehospital calcium and early in hospital vasopressin in patients at risk of hemorrhagic shock.

Conditions Studied

Trauma Hemorrhage

Interventions

  • DRUG Calcium Gluconate
  • DRUG Vasopressin
  • DRUG saline placebo

Study Locations (13)

Pennsylvania

  • Allegheny Health Network - Pittsburgh
  • University of Pittsburgh - Pittsburgh

Arizona

  • University of Arizona - Tucson

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

California

  • Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco - San Francisco

Colorado

  • Denver Health Medical Center - Denver

Florida

  • University of Miami - Miami

Minnesota

  • Hennepin County Medical Center - Minneapolis

Missouri

  • University of Missouri Health Care - Columbia

Trial Details

FieldValue
Enrollment Target 1,050 participants
Start Date 2024-06-30
Est. Completion 2028-03
Phase Phase 2

Sponsor

Jason Sperry

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05958342

The ClinicalTrials.gov registry entry for NCT05958342 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 1,050 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 289-participant average among 56 other Trauma trials with a reported enrollment target (263% higher). The listed sponsor is Jason Sperry, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Trauma appearing as the primary indexed condition, and to 3 interventions - of which Calcium Gluconate is the first listed.

NCT05958342 reports 13 study locations spanning 12 distinct geographic areas - top geographies include Pennsylvania, Arizona, Arkansas.

Frequently Asked Questions

What is clinical trial NCT05958342 about?

NCT05958342 is a clinical study titled "CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial". The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to determine the efficacy and safety of prehospital calcium and early in hospital vasopressin in patie...

What is the current status of trial NCT05958342?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 1,050 participants. The study started on 2024-06-30. Estimated completion is 2028-03.

What conditions does trial NCT05958342 study?

This clinical trial studies the following conditions: Trauma, Hemorrhage.

What interventions are being tested in trial NCT05958342?

The interventions under investigation include: Calcium Gluconate (DRUG), Vasopressin (DRUG), saline placebo (DRUG).

Who is sponsoring clinical trial NCT05958342?

This trial is sponsored by Jason Sperry, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05958342 being conducted?

This trial has 13 study locations across Arizona, Arkansas, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Trauma

All registered trials for this condition

Hemorrhage

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.